Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …

Background Metabolic associated fatty liver disease (MAFLD) is a novel terminology
introduced in 2020 to provide a more accurate description of fatty liver disease associated …

Abstract “Metabolic dysfunction-associated fatty liver disease (MAFLD)” is the term
suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation …

There is some dissatisfaction with the term “nonalcoholic fatty liver disease (NAFLD),” which
overemphasizes alcohol and underemphasizes the importance of metabolic risk factors in …

Abstract Background & Aims The applicability of the novel metabolic dysfunction associated
fatty liver disease (MAFLD) definition has been studied in numerous cohorts and compared …

Nonalcoholic fatty liver disease (NAFLD) affects about a third of the world's adult population
and is a major public health concern. NAFLD is defined by the presence of hepatic steatosis …

Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …

Non-alcoholic fatty liver disease (NAFLD) is defined as a chronic liver disease characterized
by excessive fat accumulation in the liver without another obvious cause (no excessive …

Recently, international expert panels have proposed a new definition of fatty liver: metabolic
dysfunction‐associated fatty liver disease (MAFLD). MAFLD is not just a simple renaming of …

Nonalcoholic fatty liver disease (NAFLD), also named metabolic dysfunction-associated fatty
liver disease (MAFLD), is a progressive disease spectrum encompassing simple steatosis …